Skip to content

13F-HR filed by GREAT POINT PARTNERS LLC

GREAT POINT PARTNERS LLC filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 30 holding rows worth $242,495,757.

Accession
0001814554-25-000164
Filed
2025-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2025

A holdings report, 30 entries on the cover page, a total value of $242,495,757 stated on the cover page (in dollars after the unit check, H1), rows summing to $242,495,757 with VALUE read as dollars as filed, 13F file number 028-11743. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AMYLYX PHARMACEUTICALS INC03237H101COM1,700,000$23,103,000dollars as filed
REZOLUTE INC76200L309COMMON STOCK2,451,809$23,047,005dollars as filed
NEKTAR THERAPEUTICS640268306COMMON STOCK300,000$17,070,000dollars as filed
ZURA BIO LTDG9TY5A101COMMON STOCK3,815,930$16,522,977dollars as filed
SOLENO THERAPEUTICS INC834203309COM225,000$15,210,000dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR75,000$14,910,750dollars as filed
ABIVAX SA-00370M103SPONSORED ADS150,000$12,735,000dollars as filed
APOGEE THERAPEUTICS INC COM03770N101Stock304,000$12,077,920dollars as filed
DIANTHUS THERAPEUTICS INC252828108COM265,803$10,459,348dollars as filed
CYTOKINETICS INC23282W605COM NEW150,000$8,244,000dollars as filed
IMMUNOVANT INC45258J102COM500,000$8,060,000dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock200,000$8,030,000dollars as filed
NEUROGENE INC64135M105COMMON STOCK446,814$7,743,287dollars as filed
EUPRAXIA PHARMACEUTICALS INC29842P105COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/11,200,000$7,080,000dollars as filed
UPSTREAM BIO INC91678A107COMMON STOCK300,000$5,643,000dollars as filed
JADE BIOSCIENCES INC008064206COM NEW632,599$5,459,329dollars as filed
IONIS PHARMACEUTICALS INC COM462222100Stock80,000$5,233,600dollars as filed
AKERO THERAPEUTICS INC00973Y108COM103,848$4,930,703dollars as filed
TAYSHA GENE THERAPIES INC877619106COMMON STOCK1,500,000$4,905,000dollars as filed
CONTEXT THERAPEUTICS INC21077P108COM4,683,711$4,537,579dollars as filed
PHARVARIS NVN69605108COMMON STOCK155,105$3,869,870dollars as filed
DBV TECHNOLOGIES S A23306J309SPONSORED ADS378,594$3,785,940dollars as filed
LEGEND BIOTECH CORP52490G102SPONSORED ADS113,460$3,699,931dollars as filed
ORUKA THERAPEUTICS INC COM687604108Stock183,330$3,525,436dollars as filed
UNICYCIVE THERAPEUTICS INC90466Y202COMMON STOCK796,558$3,472,993dollars as filed
SANA BIOTECHNOLOGY INC799566104COM700,000$2,485,000dollars as filed
ABSCI CORPORATION00091E109COM796,438$2,421,172dollars as filed
HARMONY BIOSCIENCES HLDGS IN413197104COM85,000$2,342,600dollars as filedcall
PLIANT THERAPEUTICS INC729139105COM850,000$1,258,000dollars as filed
CAPRICOR THERAPEUTICS INC14070B309COMMON STOCK87,700$632,317dollars as filedput

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001814554-25-000164this filing2025-11-14acceptance time not in the bulk data set